Jump to main content
Jump to site search

Issue 11, 2016
Previous Article Next Article

Tuning the metabolism of the anticancer drug cisplatin with chemoprotective agents to improve its safety and efficacy

Author affiliations

Abstract

Numerous in vivo studies have shown that the severe toxic side-effects of intravenously administered cisplatin can be significantly reduced by the co-administration of sulfur-containing ‘chemoprotective agents’. Using a metallomics approach, a likely biochemical basis for these potentially useful observations was only recently uncovered and appears to involve the reaction of chemoprotective agents with cisplatin-derived Pt-species in human plasma to form novel platinum–sulfur complexes (PSC's). We here reveal aspects of the structure of two PSC's and establish the identification of an optimal chemoprotective agent to ameliorate the toxic side-effects of cisplatin, while leaving its antineoplastic activity largely intact, as a feasible research strategy to transform cisplatin into a safer and more effective anticancer drug.

Graphical abstract: Tuning the metabolism of the anticancer drug cisplatin with chemoprotective agents to improve its safety and efficacy

Back to tab navigation
Please wait while Download options loads

Publication details

The article was received on 18 Aug 2016, accepted on 08 Sep 2016, published on 26 Sep 2016 and first published online on 26 Sep 2016


Article type: Minireview
DOI: 10.1039/C6MT00183A
Citation: Metallomics, 2016,8, 1170-1176
  • Open access: Creative Commons BY-NC license
  •   Request permissions

    Tuning the metabolism of the anticancer drug cisplatin with chemoprotective agents to improve its safety and efficacy

    M. Sooriyaarachchi, G. N. George, I. J. Pickering, A. Narendran and J. Gailer, Metallomics, 2016, 8, 1170
    DOI: 10.1039/C6MT00183A

Search articles by author